Creative BioMart Released a Bunch of COVID-19 and Other CoV Proteins for Research Use

Creative BioMart released a bunch of COVID-19 and other CoV proteins products to support coronavirus research.

February 27, 2020 /MarketersMedia/ —

Currently, no vaccines or antiviral drugs have been developed to prevent or treat the SARS-CoV-2 (officially named COVID-19) outbreak that is spreading and rising death toll quickly. As a world leading biotech company, Creative BioMart is fully supportive of the COVID-19 research. The company released a bunch of COVID-19 and other CoV proteins products to support coronavirus research.

Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to the more severe such as Middle East Respiratory Syndrome (MERS-CoV), Severe Acute Respiratory Syndrome (SARS-CoV), and the current SARS-CoV-2. Symptoms can vary in different species. So far, no vaccines or antiviral drugs have been developed to prevent or treat human coronavirus infections.

Taking advantage of its scientific expertise, high-quality products, and abundant experience, Creative BioMart is glad to provide a full set of SARS-CoV-2 recombinant proteins, including full length S protein (ECD), the S1 subunit, the S2 subunit, the S1 RBD, the N protein, and the possible target ACE2.

Besides, Creative BioMart also provides SARS-CoV, MERS-CoV, and other CoV related proteins to build on the existing SARS and MERS coronavirus research and identify knowledge gaps and research priorities to minimize the impact of the COVID-19 outbreak.

SARS-CoV-2 Recombinant Proteins products in Creative BioMart include but are not limited to: Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit receptor binding domain (RBD), Mouse IgG1 Fc-tagged, Recombinant COVID-19 (2019 novel coronavirus)
Spike protein S1 subunit, His-tagged, Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit, Human IgG1 Fc-tagged, Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit, Mouse IgG1 Fc-tagged, etc.

Other CoV Protein Products include: Recombinant SARS-CoV(Beijing 02) S(1-1190) protein, Recombinant SARS-CoV(Beijing 02) S(RBD) protein, Recombinant MERS-CoV(EMC 2C/2012) S(1-1190) protein, etc.

Download this file to know more detailed information about the COVID-19 and Other CoV Proteins products provided by Creative BioMart: https://www.creativebiomart.net/resource/pdfdownload/List-of-SARS-CoV-2-and-Other-CoV-Related-Proteins.pdf.

About Creative BioMart
Starting from a small supplier of proteins and enzymes for academic institutes and biotech companies, Creative BioMart has always been focusing on developing high quality protein products like recombinant proteins, native proteins, GMP proteins, etc. and efficient protein manufacturing services including protein expression, protein labeling, protein interaction etc.

Contact Info:
Name: Caroline Green
Email: Send Email
Organization: Creative BioMart
Website: https://www.creativebiomart.net/

Source URL: https://marketersmedia.com/creative-biomart-released-a-bunch-of-covid-19-and-other-cov-proteins-for-research-use/88948112

Source: MarketersMedia

Release ID: 88948112

More News From Technology - Asia Logue

Chinese report says illnesses may be from new coronavirus

Apr 5, 2020

BEIJING — A preliminary investigation into viral pneumonia illnesses sickening dozens of people in and around China has identified the possible cause as a new type of coronavirus, state media said Thursday. Chinese health authorities did not immediately confirm the report from state broadcaster CCTV. Coronaviruses are spread through coughing or sneezing or by touching an infected person. Some cause the common cold and others can lead to more severe respiratory diseases, such as SARS and MERS. Such viruses are common in people but more exotic versions from bats, camels and other animals have caused severe illness. The novel coronavirus...

Sign up now!

Advertisement

About Us

Asialogue holds a collection of past news for readers to understand what happened before these latest events.